Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc.（FHTX）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · FHTX · 截至 2025年9月30日
股东结构概览
88
机构持有人数
▲ 8 vs Q2
$200.24M
机构持仓总市值
▲ $7.69M vs Q2
58.71M
总流通股
freeFloat 46.68%
40.90M
13F 申报持股数
▼ 66,177 vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
FHTX 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
FLAGSHIP PIONEERING INC. pharmaceutical preparations | 12.67M | 20.12% | 20.12% | $61.98B | Nov 14, 2025 | — held |
FMR LLC pharmaceutical preparations | 5.47M | 8.69% | 8.69% | $26.77B | Nov 13, 2025 | ▼ 60.0K |
BVF INC/IL pharmaceutical preparations | 5.30M | 8.42% | 8.42% | $25.93B | Nov 14, 2025 | — held |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) pharmaceutical preparations | 3.26M | 5.17% | 5.17% | $15.92B | Nov 14, 2025 | — held |
RAYMOND JAMES FINANCIAL INC pharmaceutical preparations | 2.46M | 3.91% | 3.91% | $12.04B | Nov 14, 2025 | ▲ 95.2K |
BLACKROCK, INC. pharmaceutical preparations | 2.26M | 3.59% | 3.59% | $11.05B | Nov 12, 2025 | ▲ 30.8K |
VANGUARD GROUP INC pharmaceutical preparations | 1.90M | 3.02% | 3.02% | $9.29B | Nov 7, 2025 | ▲ 14.8K |
EUCLIDEAN CAPITAL LLC pharmaceutical preparations | 1.57M | 2.50% | 2.50% | $7.70B | Nov 14, 2025 | — held |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 808.5K | 1.28% | 1.28% | $3.95B | Nov 12, 2025 | ▲ 814 |
SIREN, L.L.C. pharmaceutical preparations | 720.7K | 1.14% | 1.14% | $3.52B | Nov 13, 2025 | — held |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
19
增持
+632.4K 股4
新建仓
首次建仓16
减持
−618.9K 股0
清仓
完全退出净股数变化（前50家）
+13.5K
+632.4K / −618.9K
净新增持仓人
+7
新建 4 个 / 退出 0 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
FHTX 内幕交易记录
数据来源：SEC Form 4
10
买入笔数
0
卖出笔数
0.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
GOTTSCHALK ADRIAN Chief Executive Officer | Apr 10, 2026 | Gift | 59,208 | — | — | 270.9K | Form 4 ↗ |
GOTTSCHALK ADRIAN Chief Executive Officer | Apr 10, 2026 | Gift | 59,208 | — | — | 240.8K | Form 4 ↗ |
GOTTSCHALK ADRIAN Chief Executive Officer | Apr 9, 2026 | Gift | 47,497 | — | — | 211.7K | Form 4 ↗ |
GOTTSCHALK ADRIAN Chief Executive Officer | Apr 9, 2026 | Gift | 47,497 | — | — | 0 | Form 4 ↗ |
Maynard Ryan D Chief Financial Officer | Feb 23, 2026 | Award | 400,000 | $5.75 | $2.30M | 400.0K | Form 4 ↗ |
GOTTSCHALK ADRIAN Chief Executive Officer | Feb 5, 2026 | Award | 1,075,000 | $5.23 | $5.62M | 1.07M | Form 4 ↗ |
Costa Carlos Chief People Officer | Jan 30, 2026 | Award | 230,000 | $5.71 | $1.31M | 230.0K | Form 4 ↗ |
LaCascia Michael Chief Legal Officer | Jan 30, 2026 | Award | 295,000 | $5.71 | $1.68M | 295.0K | Form 4 ↗ |
Cardama Alfonso Quintas Chief Medical Officer | Jan 30, 2026 | Award | 300,000 | $5.71 | $1.71M | 300.0K | Form 4 ↗ |
Rivkin Anna Chief Business Officer | Jan 30, 2026 | Award | 165,000 | $5.71 | $942.1K | 165.0K | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Foghorn Therapeutics Inc.（FHTX）主要由机构投资者持有，机构持股比例约为 69.7%。公司内部人员持股约 53.32%，散户及公众持股约占剩余的 0.00%。
Foghorn Therapeutics Inc. 最大机构股东为 FLAGSHIP PIONEERING INC.，截至 September 30, 2025 持有约 12.67 million 股，占总流通股的 20.12%。
目前共有 88 家机构持有 FHTX 股票，合计持仓市值约 $200,237,661，数据来源为最新 SEC 13F 申报。
常见问题
FHTX ownershipFoghorn Therapeutics Inc.（FHTX）主要由机构投资者持有，机构持股约 69.7%。最大股东为 FLAGSHIP PIONEERING INC.，持股比例 20.12%。内部人员持股约 53.32%。数据来源 SEC Form 13F，截至 September 30, 2025。